Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$31,000.00

Determinants of Natural Killer Cell Ly49 Receptor Specificity

FY 2017-18

Summary
Natural killer (NK) cells are lymphocytes that act as a first line of defense against viruses and tumours, destroying pathologically altered cells. NK cells express inhibitory receptors specific for class I (CI) major histocompatiblity complex molecules ubiquitously expressed on healthy cells. Lack of engagement of NK inhibitory receptors, due to loss of CI expression that typically occurs with virus-infected cells or tumour cells, releases inhibition of NK cells, allowing them to destroy such altered cells. Ly49 are large families of major class of CI-specific receptors expressed by mouse and rat NK cells, but not humans. CI associate with beta-2 microglobulin (b2m) and bind and present peptide fragments from intracellular proteolytic events. We, and others, have found that the identity of the CI-bound peptide can determine Ly49 recognition of CI. What is unclear, is the nature of endogenous peptides in healthy cells that regulate NK cells, and the in vivo significance of peptide selectivity by Ly49. Our long-term goal is to understand the molecular basis of peptide selectivity of Ly49 recognition. The significance and uniqueness of this undertaking is that it directly addresses the very fundamental biological question of the molecular basis of healthy cell recognition by NK cells. Furthermore, understanding Ly49 recognition, may provide novel insights into host resistance to infections such as hanta viruses in mice, and possibly diseases in horses, a species which also has an expanded Ly49 gene family. We hypothesize that certain and specific endogenous peptides support CI recognition by Ly49, identification of which will provide a window into the purpose of Ly49 surveillance. We also hypothesize that peptide selectivity determines Ly49 affinity thresholds, and has in vivo significance. To test these hypotheses, we propose the following objectives: 1. Assess diversity and identity of endogenous peptides controlling Ly49C recognition. Advances in mass spectrometry have identified endogenous peptides bound to CI. We will examine individual endogenous peptides bound to CI (K b ) in supporting Ly49C recognition, including their molecular properties and proteins of origin (from peptide sequence database matching), in contributing to the control of Ly49C recognition. 2. Define the influence of CI bound peptide identity in determining Ly49 affinity. We will determine the affinities of Ly49C for different CI (K b )-peptide complexes by surface plasmon resonance. This should reveal whether there are threshold affinities for Ly49C interaction controlled by identities of bound peptides. 3. Determine the influence of Ly49 peptide selectivity on NK cell activity in vivo . By transgenesis on a b2m - / - background we will express genetically engineered single chain peptide-CI complexes to determine the ability of distinct individual peptides to support licensing and function of NK cells in vivo .
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-03744
Name nom
Kane, Kevin
Department département
Medical Microbiology and Immunology - Medical Microbiology and Immunology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5401
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Immunochemistry
Research subject fr
Chimie immunologique
Partie
2
Nb partie
5
Application title
Determinants of Natural Killer Cell Ly49 Receptor Specificity
Keyword
NSERC
Application summary
Natural killer (NK) cells are lymphocytes that act as a first line of defense against viruses and tumours, destroying pathologically altered cells. NK cells express inhibitory receptors specific for class I (CI) major histocompatiblity complex molecules ubiquitously expressed on healthy cells. Lack of engagement of NK inhibitory receptors, due to loss of CI expression that typically occurs with virus-infected cells or tumour cells, releases inhibition of NK cells, allowing them to destroy such altered cells. Ly49 are large families of major class of CI-specific receptors expressed by mouse and rat NK cells, but not humans. CI associate with beta-2 microglobulin (b2m) and bind and present peptide fragments from intracellular proteolytic events. We, and others, have found that the identity of the CI-bound peptide can determine Ly49 recognition of CI. What is unclear, is the nature of endogenous peptides in healthy cells that regulate NK cells, and the in vivo significance of peptide selectivity by Ly49. Our long-term goal is to understand the molecular basis of peptide selectivity of Ly49 recognition. The significance and uniqueness of this undertaking is that it directly addresses the very fundamental biological question of the molecular basis of healthy cell recognition by NK cells. Furthermore, understanding Ly49 recognition, may provide novel insights into host resistance to infections such as hanta viruses in mice, and possibly diseases in horses, a species which also has an expanded Ly49 gene family. We hypothesize that certain and specific endogenous peptides support CI recognition by Ly49, identification of which will provide a window into the purpose of Ly49 surveillance. We also hypothesize that peptide selectivity determines Ly49 affinity thresholds, and has in vivo significance. To test these hypotheses, we propose the following objectives: 1. Assess diversity and identity of endogenous peptides controlling Ly49C recognition. Advances in mass spectrometry have identified endogenous peptides bound to CI. We will examine individual endogenous peptides bound to CI (K b ) in supporting Ly49C recognition, including their molecular properties and proteins of origin (from peptide sequence database matching), in contributing to the control of Ly49C recognition. 2. Define the influence of CI bound peptide identity in determining Ly49 affinity. We will determine the affinities of Ly49C for different CI (K b )-peptide complexes by surface plasmon resonance. This should reveal whether there are threshold affinities for Ly49C interaction controlled by identities of bound peptides. 3. Determine the influence of Ly49 peptide selectivity on NK cell activity in vivo . By transgenesis on a b2m - / - background we will express genetically engineered single chain peptide-CI complexes to determine the ability of distinct individual peptides to support licensing and function of NK cells in vivo .